2022年

• Dankers W, Northcott M, Bennett T, D’Cruz A, Sherlock R, Gearing LJ, Hertzog P, Russ B, Miceli I, Scheer S, Fujishiro M, Hayakawa K, Ikeda K, Morand EF, Jones SA. Type 1 interferon suppresses expression and glucocorticoid induction of glucocorticoid-induced leucine zipper (GILZ). Front Immunol. 2022;13:1034880. https://www.ncbi.nlm.nih.gov/pubmed/36505447
• Hayakawa K, Fujishiro M, Yoshida Y, Kataoka Y, Sakuma S, Nishi T, Ikeda K, Morimoto S, Takamori K, Sekigawa I. Exposure of female NZBWF1 mice to imiquimod-induced lupus nephritis at an early age via a unique mechanism that differed from spontaneous onset. Clin Exp Immunol. 2022;208(1):33-46. https://www.ncbi.nlm.nih.gov/pubmed/35260898

2021年

• Matsuoka Y, Morimoto S, Fujishiro M, Hayakawa K, Kataoka Y, Suzuki S, Ikeda K, Takamori K, Yamaji K, Tamura N. Metformin repositioning in rheumatoid arthritis. Clin Exp Rheumatol. 2021;39(4):763-8. https://www.ncbi.nlm.nih.gov/pubmed/32828146

2020年

• Yoshida Y, Hayakawa K, Fujishiro M, Ikeda K, Tsushima H, Hirai T, Kawasaki M, Tominaga M, Suga Y, Takamori K, Watanabe Y, Sekigawa I, Morimoto S. Social defeat stress exacerbates atopic dermatitis through downregulation of DNA methyltransferase 1 and upregulation of C-C motif chemokine receptor 7 in skin dendritic cells. Biochem Biophys Res Commun. 2020;529(4):1073-9. https://www.ncbi.nlm.nih.gov/pubmed/32819567

2019年

• Hayakawa K, Kawasaki M, Hirai T, Yoshida Y, Tsushima H, Fujishiro M, Ikeda K, Morimoto S, Takamori K, Sekigawa I. MicroRNA-766-3p Contributes to Anti-Inflammatory Responses through the Indirect Inhibition of NF-kappaB Signaling. Int J Mol Sci. 2019;20(4):809. https://www.ncbi.nlm.nih.gov/pubmed/30769772

2018年

• Ikeda K, Sekiguchi N, Hirai T, Tanji K, Zushi A, Inoue M, Takasago M, Komatsu T, Morimoto S, Yamaji K, Takamori K, Tamura N, Sekigawa I.
  Securely collecting multidimensional health information from patients with rheumatoid arthritis using smart device technology: Beneficial effect for physicians and patients.
  Musculoskeletal Care. 2018 Dec;16(4):494-499.
• Hayakawa K, Ikeda K, Fujishiro M, Yoshida Y, Hirai T, Tsushima H, Miyashita T, Morimoto S, Suga Y, Takamori K, Ogawa H, Sekigawa I.
  Connective Tissue Growth Factor Neutralization Aggravates the Psoriasis Skin Lesion: The Analysis of Psoriasis Model Mice and Patients.
  Ann Dermatol. 2018 Feb;30(1):47-53.
• Hirai T, Ikeda K, Tsushima H, Fujishiro M, Hayakawa K, Yoshida Y, Morimoto S, Yamaji K, Takasaki Y, Takamori K, Tamura N, Sekigawa I.
  Circulating plasma microRNA profiling in patients with polymyositis/dermatomyositis before and after treatment: miRNA may be associated with polymyositis/dermatomyositis.
  Inflamm Regen. 2018 Jan 8;38:1.

2017年

• Ikeda K, Hayakawa K, Fujishiro M, Kawasaki M, Hirai T, Tsushima H, Miyashita T, Suzuki S, Morimoto S, Tamura N, Takamori K, Ogawa H, Sekigawa I.
  JAK inhibitor has the amelioration effect in lupus-prone mice: the involvement of IFN signature gene downregulation.
  BMC Immunol. 2017 Aug 22;18(1):41.
• Tsushima H, Morimoto S, Fujishiro M, Yoshida Y, Hayakawa K, Hirai T, Miyashita T, Ikeda K, Yamaji K, Takamori K, Takasaki Y, Sekigawa I, Tamura N.
  Kinase inhibitors of the IGF-1R as a potential therapeutic agent for rheumatoid arthritis.
  Autoimmunity. 2017 Aug;50(5):329-335.
• Nozawa K, Doe K, Uomori K, Sekigawa I, Takasaki Y, Yamaji K, Tamura N.
  Antiribonuclease H2 antibodies are an immune biomarker for systemic lupus erythematosus.
  Autoimmunity. 2017 Jun;50(4):241-246.
• Ikeda K, Watanabe K, Hirai T, Tanji K, Miyashita T, Nakajima S, Uomori K, Morimoto S, Takamori K, Ogawa H, Takasaki Y, Sekigawa I.
  Mizoribine Synchronized Methotrexate Therapy should be Considered when Treating Rheumatoid Arthritis Patients with an Inadequate Response to Various Combination Therapies.
  Intern Med. 2017;56(10):1147-1152.
• Hirai T, Ikeda K, Fujishiro M, Tsushima H, Hayakawa K, Suzuki S, Yamaguchi A, Nozawa K, Morimoto S, Takasaki Y, Ogawa H, Takamori K, Tamura N, Sekigawa I.
  The effectiveness of new triple combination therapy using synthetic disease-modifying anti-rheumatic drugs with different pharmacological function against rheumatoid arthritis: the verification by an in vitro and clinical study.
  Clin Rheumatol. 2017 Jan;36(1):51-58.
• Matsuki-Muramoto Y, Nozawa K, Uomori K, Sekigawa I, Takasaki Y.
  Bortezomib treatment prevents glomerulosclerosis associated with lupus nephritis in a murine model through suppressive effects on the immune and renin-angiotensin systems.
  Mod Rheumatol. 2017 Jan;27(1):77-86.

2016年

• Ikeda K, Takasaki Y, Sekigawa I.
  Rapid onset of small intestinal perforation after successful steroid treatment in eosinophilic granulomatosis with polyangiitis.
  Mod Rheumatol. 2016 Nov;26(6):968-970.
• Yamada Y, Nozawa K, Nakano S, Mitsuo Y, Hiruma K, Doe K, Sekigawa I, Yamanaka K, Takasaki Y.
  Antibodies to microtubule-associated protein-2 in the cerebrospinal fluid are a useful diagnostic biomarker for neuropsychiatric systemic lupus erythematosus.
  Mod Rheumatol. 2016 Jul;26(4):562-8.
• Miyashita T, Morimoto S, Fujishiro M, Hayakawa K, Suzuki S, Ikeda K, Miyazawa K, Morioka M, Takamori K, Ogawa H, Sekigawa I, Takasaki Y.
  Inhibition of each module of connective tissue growth factor as a potential therapeutic target for rheumatoid arthritis.
  Autoimmunity. 2016;49(2):109-14.

2015年

• Nakano S, Morimoto S, Suzuki S, Tsushima H, Yamanaka K, Sekigawa I, Takasaki Y.
  Immunoregulatory role of IL-35 in T cells of patients with rheumatoid arthritis.
  Rheumatology (Oxford). 2015 Aug;54(8):1498-506.
• Suzuki S, Morimoto S, Fujishiro M, Kawasaki M, Hayakawa K, Miyashita T, Ikeda K, Miyazawa K, Yanagida M, Takamori K, Ogawa H, Sekigawa I, Takasaki Y.
  Inhibition of the insulin-like growth factor system is a potential therapy for rheumatoid arthritis.
  Autoimmunity. 2015 Jun;48(4):251-8.

2014年

• Nozawa K, Fujishiro M, Takasaki Y, Sekigawa I.
  Inhibition of rheumatoid arthritis by blocking connective tissue growth factor.
  World J Orthop. 2014 Nov 18;5(5):653-9.
• Doe K, Nozawa K, Hiruma K, Yamada Y, Matsuki Y, Nakano S, Ogasawara M, Nakano H, Ikeda T, Ikegami T, Fujishiro M, Kawasaki M, Ikeda K, Amano H, Morimoto S, Ogawa H, Takamori K, Sekigawa I, Takasaki Y.
  Antibody against chromatin assembly factor-1 is a novel autoantibody specifically recognized in systemic lupus erythematosus.
  Lupus. 2014 Sep;23(10):1031-41.

2013年

• Yanagida M, Kawasaki M, Fujishiro M, Miura M, Ikeda K, Nozawa K, Kaneko H, Morimoto S, Takasaki Y, Ogawa H, Takamori K, Sekigawa I.
  Serum proteome analysis in patients with rheumatoid arthritis receiving therapy with tocilizumab: an anti-interleukin-6 receptor antibody.
  Biomed Res Int. 2013;2013:607137.
• Yamaguchi A, Nozawa K, Fujishiro M, Kawasaki M, Suzuki F, Takamori K, Ogawa H, Takasaki Y, Sekigawa I.
  CC motif chemokine ligand 13 is associated with rheumatoid arthritis pathogenesis.
  Mod Rheumatol. 2013 Sep;23(5):856-63.
• Nozawa K, Fujishiro M, Kawasaki M, Yamaguchi A, Ikeda K, Morimoto S, Iwabuchi K, Yanagida M, Ichinose S, Morioka M, Ogawa H, Takamori K, Takasaki Y, Sekigawa I.
  Inhibition of connective tissue growth factor ameliorates disease in a murine model of rheumatoid arthritis.
  Arthritis Rheum. 2013 Jun;65(6):1477-86.

2012年

• Yanagida M, Jung G, Tanaka Y, Sone S, Fujishiro M, Ikeda K, Nozawa K, Kaneko H, Takasaki Y, Ogawa H, Takamori K, Sekigawa I.
  Serum proteome analysis in patients with rheumatoid arthritis receiving therapy with etanercept, a chimeric tumor necrosis factor-alpha receptor.
  Int J Rheum Dis. 2012 Oct;15(5):486-95.
• Yamaguchi A, Nozawa K, Fujishiro M, Kawasaki M, Takamori K, Ogawa H, Sekigawa I, Takasaki Y.
  Estrogen inhibits apoptosis and promotes CC motif chemokine ligand 13 expression on synovial fibroblasts in rheumatoid arthritis.
  Immunopharmacol Immunotoxicol. 2012 Oct;34(5):852-7.
• Fujishiro M, Nozawa K, Kawasaki M, Yamaguchi A, Iwabuchi K, Yanagida M, Suzuki F, Miyazawa K, Fukui H, Kaneko K, Ogawa H, Takamori K, Takasaki Y, Sekigawa I.
  Regenerating gene (REG) 1 alpha promotes pannus progression in patients with rheumatoid arthritis.
  Mod Rheumatol. 2012 Apr;22(2):228-37.

2011年

• Kawasaki M, Fujishiro M, Yamaguchi A, Nozawa K, Kaneko H, Takasaki Y, Takamori K, Ogawa H, Sekigawa I.
  Possible role of the JAK/STAT pathways in the regulation of T cell-interferon related genes in systemic lupus erythematosus.
  Lupus. 2011 Oct;20(12):1231-9.
• Yamada R, Nozawa K, Yoshimine T, Takasaki Y, Ogawa H, Takamori K, Sekigawa I.
  A Case of Thrombotic Thrombocytopenia Purpura Associated with Systemic Lupus Erythematosus: Diagnostic Utility of ADAMTS-13 Activity.
  Autoimmune Dis. 2011;2011:483642.

2010年

• Kawasaki M, Fujishiro M, Yamaguchi A, Nozawa K, Kaneko H, Takasaki Y, Takamori K, Ogawa H, Sekigawa I.
  Fluctuations in the gene expression of peripheral blood mononuclear cells between the active and inactive phases of systemic lupus erythematosus.
  Clin Exp Rheumatol. 2010 May-Jun;28(3):311-7.
• Sekigawa I, Fujishiro M, Yamaguchi A, Kawasaki M, Inui A, Nozawa K, Takasaki Y, Takamori K, Ogawa H.
  A new hypothesis of the possible mechanisms of gender differences in systemic lupus erythematosus.
  Clin Exp Rheumatol. 2010 May-Jun;28(3):419-23.

2009年

• Nozawa K, Kaneko H, Itoh T, Katsura Y, Noguchi M, Suzuki F, Takasaki Y, Ogawa H, Takamori K, Sekigawa I.
  Synchronous malignant B-cell lymphoma and gastric tubular adenocarcinoma associated with paraneoplastic cutaneous vasculitis: hypereosinophilic syndrome with mixed cryoglobulinemia is an important sign of paraneoplastic syndrome.
  Rare Tumors. 2009 Dec 28;1(2):e42.
• Nozawa K, Fujishiro M, Kawasaki M, Kaneko H, Iwabuchi K, Yanagida M, Suzuki F, Miyazawa K, Takasaki Y, Ogawa H, Takamori K, Sekigawa I.
  Connective tissue growth factor promotes articular damage by increased osteoclastogenesis in patients with rheumatoid arthritis.
  Arthritis Res Ther. 2009;11(6):R174.
• Kawasaki M, Sekigawa I, Nozawa K, Kaneko H, Takasaki Y, Takamori K, Ogawa H.
  Changes in the gene expression of peripheral blood mononuclear cells during the menstrual cycle of females is associated with a gender bias in the incidence of systemic lupus erythematosus.
  Clin Exp Rheumatol. 2009 Mar-Apr;27(2):260-6.
• Nozawa K, Ikeda K, Satoh M, Reeves WH, Stewart CM, Li YC, Yen TJ, Rios RM, Takamori K, Ogawa H, Sekigawa I, Takasaki Y, Chan EK.
  Autoantibody to NA14 is an independent marker primarily for Sjogren’s syndrome.
  Front Biosci (Landmark Ed). 2009 Jan 1;14:3733-9.

2008年

• Sekigawa I, Kaneda K, Kaneko H, Takasaki Y, Takamori K, Ogawa H.
  Detection of serum IgE class anti-SSA antibodies in mothers with foetal loss.
  Rheumatol Int. 2008 May;28(7):623-6.
• Sekigawa I, Yanagida M, Iwabuchi K, Kaneda K, Kaneko H, Takasaki Y, Jung G, Sone S, Tanaka Y, Ogawa H, Takamori K.
  Protein biomarker analysis by mass spectrometry in patients with rheumatoid arthritis receiving anti-tumor necrosis factor-alpha antibody therapy.
  Clin Exp Rheumatol. 2008 Mar-Apr;26(2):261-7.

2007年

• Inui A, Ogasawara H, Naito T, Sekigawa I, Takasaki Y, Hayashida Y, Takamori K, Ogawa H.
  Estrogen receptor expression by peripheral blood mononuclear cells of patients with systemic lupus erythematosus.
  Clin Rheumatol. 2007 Oct;26(10):1675-8.

2006年

• Sekigawa I, Kawasaki M, Ogasawara H, Kaneda K, Kaneko H, Takasaki Y, Ogawa H.
  DNA methylation: its contribution to systemic lupus erythematosus.
  Clin Exp Med. 2006 Oct;6(3):99-106.
• Nakamura T, Sekigawa I, Ogasawara H, Mitsuishi K, Hira K, Ikeda S, Ogawa H.
  Expression of DNMT-1 in patients with atopic dermatitis.
  Arch Dermatol Res. 2006 Oct;298(5):253-6.